Oxyrase
Private Company
Total funding raised: $1.7M
Overview
Oxyrase is a long-established, private company that has developed a proprietary enzyme-based platform for oxygen scavenging, enabling reliable anaerobic culture conditions. Its core business revolves around supplying consumables like PRAS media and OxyPlates to clinical diagnostics labs, research institutions, and quality control laboratories, ensuring optimal growth of oxygen-sensitive microorganisms. The company has diversified its applications into biological sample preservation and industrial uses, demonstrating the versatility of its core technology. With over 30 years in operation, Oxyrase has built a reputation as a trusted supplier in the niche anaerobic microbiology market.
Technology Platform
Proprietary Oxyrase Enzyme System® for oxygen scavenging, enabling anaerobic environments for culture, preservation, and industrial applications.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Oxyrase competes with large microbiology consumables suppliers (e.g., BD, bioMérieux, Thermo Fisher) that offer anaerobic media and systems, as well as manufacturers of anaerobic chambers and gas generation equipment. Its differentiation is the proprietary, enzyme-based approach integrated into convenient, self-contained products like OxyPlates.